A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BMMs / bone marrow monocytes

[Related PubMed/MEDLINE]
Total Number of Papers: 20
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BMMs  (>> Co-occurring Abbreviation)
Long Form:   bone marrow monocytes
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis. IL, RA, Th17, THP, TNF
2020 Diterpenoids from the aerial parts of Flueggea acicularis and their activity against RANKL-induced osteoclastogenesis. ---
2019 Enhanced Activation of Rac1/Cdc42 and MITF Leads to Augmented Osteoclastogenesis in Autosomal Dominant Osteopetrosis Type II. ADOII, ClC-7, MITF, PBMCs, RANK
2019 Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis. OPG, PMOP, RANKL, TRAP
2018 18beta-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK-TRAF6 Interactions and NF-kappaB and MAPK Signaling Pathways. 18beta-GA, BMSCs, RANKL
2018 Constitutive Activation of beta-Catenin in Differentiated Osteoclasts Induces Bone Loss in Mice. micro-CT, RT-qPCR, TRAP
2018 Inhibition of osteoclastogenesis by stem cell-derived extracellular matrix through modulation of intracellular reactive oxygen species. ECM, MSCs, ROS, TRAP
2018 Inhibitory effect of Cudratricusxanthone A on osteoclast differentiation and function. CTXA
2017 Melatonin at pharmacological concentrations suppresses osteoclastogenesis via the attenuation of intracellular ROS. NF-kappaB, ROS, SIRT1, TRAP
10  2017 MiR-124 Attenuates Osteoclastogenic Differentiation of Bone Marrow Monocytes Via Targeting Rab27a. ---
11  2017 TiAl6V4 particles promote osteoclast formation via autophagy-mediated downregulation of interferon-beta in osteocytes. CM, IFN-beta, NO, OPG, RANKL, THA
12  2016 Amyloid beta Peptide Enhances RANKL-Induced Osteoclast Activation through NF-kappaB, ERK, and Calcium Oscillation Signaling. AD, ERK, RANKL
13  2016 Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation. NC, TRAP
14  2015 Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-kappaB and PI3K/Akt signaling pathways. ERK, LH, MAPK, OSCAR, PI3K, RANKL, TRAP
15  2015 miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. M-CSF, OC-TG214, PTEN, RANKL
16  2015 Saikosaponin a inhibits RANKL-induced osteoclastogenesis by suppressing NF-kappaB and MAPK pathways. ERK, JNK, M-CSF, RANKL, SSa
17  2012 Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-kappaB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. AP-1, c-Src, CADPE, JNK, M-CSF, MAPK, RANKL, TRAF6
18  2012 Critical role of filamin-binding LIM protein 1 (FBLP-1)/migfilin in regulation of bone remodeling. BMSCs, FBLP-1, OB, OCL, RANKL
19  2011 Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-kappaB and MAPK signaling pathways. AP-1, MA, RANKL
20  2002 JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. JNKs